According to recent scientific advancements, mRNA technology has revolutionized the field of vaccine development, particularly in combating infectious diseases like COVID-19. mRNA vaccines work by instructing cells to produce a protein that triggers an immune response, effectively training the body to recognize and combat the virus. This innovative approach offers faster production times and adaptability to emerging variants, making it a critical tool in modern medicine’s arsenal against pandemics. Creative Biolabs has invited Dr. Magnus A.G. Hoffmann to walk us through the application of hybrid mRNA technology in vaccine development, strategies for optimizing hybrid mRNA vaccines, and the use of this technology in developing pan-coronavirus vaccines. During this webinar, we will explore the following key topics: Introduction on the importance of vaccines to protect against pandemics and the pros and cons of current vaccine strategies, including mRNA vaccinesDescription and development of the hybrid mRNA technology that combines features of mRNA- and protein nanoparticle-based vaccinesIn vivo evaluation of the hybrid mRNA technology for SARS-CoV-2 in mice, including new data on hybrid mRNA-based booster immunizations in pre-vaccinated miceOptimization strategies for hybrid mRNA vaccines, including preliminary data on new designs that enhance expressionApplication of the hybrid mRNA vaccine technology as a pan-coronavirus vaccine platform